Co-Diagnostics, Inc.
General ticker "CODX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $14.9M (TTM average)
Co-Diagnostics, Inc. follows the US Stock Market performance with the rate: 0.2%.
Estimated limits based on current volatility of 6.4%: low 0.34$, high 0.39$
Factors to consider:
- Total employees count: 155 (+6.9%) as of 2023
- US accounted for 72.1% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Regulatory and compliance, Product development delays, Cybersecurity threats, Labor/talent shortage/retention, Operational and conduct risks
- Current price 21.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.49$, 1.38$]
- 2025-12-31 to 2026-12-31 estimated range: [0.40$, 1.15$]
Financial Metrics affecting the CODX estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -130.74 <= 0.33
- Positive: Investing cash flow per share per price, % of 76.55 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term CODX quotes
Long-term CODX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $34.22MM | $6.81MM | $3.92MM |
| Operating Expenses | $61.20MM | $49.52MM | $44.00MM |
| Operating Income | $-26.98MM | $-42.71MM | $-40.08MM |
| Non-Operating Income | $8.13MM | $4.60MM | $2.50MM |
| R&D Expense | $17.44MM | $22.96MM | $20.98MM |
| Income(Loss) | $-18.85MM | $-38.11MM | $-37.58MM |
| Taxes | $-4.61MM | $-2.78MM | $0.06MM |
| Profit(Loss)* | $-14.24MM | $-35.33MM | $-37.64MM |
| Stockholders Equity | $114.52MM | $86.01MM | $54.31MM |
| Inventory | $5.31MM | $1.66MM | $1.07MM |
| Assets | $123.09MM | $95.32MM | $64.00MM |
| Operating Cash Flow | $6.57MM | $-22.08MM | $-29.16MM |
| Capital expenditure | $1.43MM | $1.37MM | $0.75MM |
| Investing Cash Flow | $-58.17MM | $15.39MM | $17.07MM |
| Financing Cash Flow | $-14.03MM | $-1.36MM | $0.10MM |
| Earnings Per Share** | $-0.45 | $-1.20 | $-1.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.